Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-renin hypertension in incidental adrenal adenomas and response to aldosterone-targeted therapy: a prospective study.

European journal of internal medicine·2026
Same author

Adipocyte extracellular vesicles (AdEVs) promote a proinflammatory and profibrotic profile in human renal and endothelial cells in vitro.

International journal of obesity (2005)·2026
Same author

Driving hypertension: non-classic apparent mineralocorticoid excess.

Nature reviews. Endocrinology·2025
Same author

Primary Aldosteronism in a Hispanic Cohort: Responses to Mineralocorticoid Receptor Antagonism and Remission in a Case.

American journal of hypertension·2025
Same author

Influence of estradiol deficiency on the mineralocorticoid receptor response in postmenopausal women: a cross-sectional study.

Climacteric : the journal of the International Menopause Society·2025
Same author

Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort.

The lancet. Diabetes & endocrinology·2025

Related Experiment Video

Updated: Jun 28, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

[Primary aldosteronism].

Carlos E Fardella1, Lorena M Mosso, Cristian A Carvajal

  • 1Departamento de Endocrinología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. cfardella@med.puc.cl

Revista Medica De Chile
|October 25, 2008
PubMed
Summary
This summary is machine-generated.

Primary aldosteronism (PA), a common cause of hypertension, is increasingly detected using the aldosterone/renin activity ratio (ARR). Early diagnosis and subtype differentiation are crucial for managing this condition and its associated cardiovascular risks.

More Related Videos

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

Related Experiment Videos

Last Updated: Jun 28, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiology

Background:

  • Primary aldosteronism (PA) is a significant cause of hypertension.
  • Aldosterone contributes to hypertension by increasing sodium and water reabsorption and independently increases cardiovascular risk.
  • Recent studies show a high prevalence of PA (near 10%) in hypertensive patients, detected via plasma aldosterone/renin activity ratio (ARR).

Purpose of the Study:

  • To review the prevalence, diagnosis, and treatment of primary aldosteronism.
  • To explore the clinical, biochemical, and genetic characteristics of PA subtypes.
  • To emphasize the importance of confirming autonomous aldosterone secretion and differentiating PA subtypes.

Main Methods:

  • Review of current literature on primary aldosteronism.
  • Analysis of diagnostic criteria and screening methods, including ARR.
  • Classification and comparison of PA subtypes: idiopathic aldosteronism (IA), aldosterone-producing adenoma (APA), and familial hyperaldosteronism (FH).

Main Results:

  • PA is highly prevalent in hypertensive populations, with ARR serving as an effective screening tool.
  • The diagnostic workup must confirm autonomous aldosterone secretion and distinguish between subtypes like IA and APA.
  • Understanding the genetic and clinical features of subtypes like FH is essential.

Conclusions:

  • Primary aldosteronism is a common and treatable cause of hypertension with significant cardiovascular implications.
  • Accurate diagnosis and subtype identification are critical for effective management and treatment strategies.
  • Further research into the genetic basis and clinical variations of PA subtypes is warranted.